公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ABBOTT LABORATORIOS DO BRASIL LTDA取消

898 记录

产品持有公司班级有效性
Família Alinity i HSV-1 IgG80146502368ABBOTT LABORATORIOS DO BRASIL LTDAII现有
LibreView80146502374ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Família Alinity i TBI (GFAP, UCH-L1)80146502375ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Lactic Acid2 Reagent Kit80146502376ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Alinity c Lactic Acid2 Reagent Kit80146502377ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Transplant Pretreatment Tubes80146502378ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Alinity c Phosphorus2 Reagent Kit80146502383ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Phosphorus2 Reagent Kit80146502384ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Família ARCHITECT TBI (GFAP, UCH-L1)80146502388ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Família Alinity m BKV80146502389ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Alinity m Urine Transport Kit80146502390ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Família Calcium280146502393ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Folate Lysis Reagent80146502398ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Família Alinity m Specimen Buffer80146502400ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Família ARCHITECT Lipase280146502401ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Família Alinity c Lipase280146502402ABBOTT LABORATORIOS DO BRASIL LTDAII现有
simpli-Collect HPV Collection Kit80146502414ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Direct Bilirubin80146502415ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Alinity c Direct Bilirubin Reagent Kit80146502416ABBOTT LABORATORIOS DO BRASIL LTDAII现有
ARCHITECT Total T3 Manual Diluent80146502417ABBOTT LABORATORIOS DO BRASIL LTDAI现有
Multichem LPS80146502418ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Família ACE80146502419ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Família ACE for Alinity80146502420ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Família Alinity c Cystatin C80146502423ABBOTT LABORATORIOS DO BRASIL LTDAII现有
Alinity i Anti-HBs Specimen Diluent80146502427ABBOTT LABORATORIOS DO BRASIL LTDAI现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家